Biography

Dr. McMaster received an M.D. from the Bowman Gray School of Medicine of Wake Forest University in 1984, then trained in Internal Medicine and Medical Oncology at Vanderbilt University. Following a postdoctoral fellowship in cellular biology, she came to NIH in 1996, where she completed training in Clinical Medical Genetics. She joined NCI in 1998 to pursue clinical research in cancer genetics with an emphasis on familial cancer syndromes.

Research Interests

• Clinical and genetic characterization of familial Waldenström’s macroglobulinemia
• Clinical, genetic and epidemiologic characterization of families at high risk of chronic lymphoproliferative disorders
• Epidemiologic studies in familial testis cancer: histopathologic correlates and risk of cancers other than germ cell tumors in relatives of testis cancer patients

Keywords

• cancer genetics, family studies, chronic lymphoproliferative disorders, Waldenström’s macroglobulinemia, Hodgkin Lymphoma, non-Hodgkin’s lymphoma, multiple myeloma, testicular cancer

Selected Publications

• McMaster ML, Csako G, Giambarresi TR, Vasquez L, Berg M, Saddlemire S, Hulley B, Tucker MA. Long-term evaluation of three multiple-case Waldenström macroglobulinemia families. Clin Cancer Res 2007;13:5063-5069.
• Crockford GP, Linger R, Hockley S, …McMaster M, et al. Genome-wide linkage screen for testicular germ cell tumour susceptibililty loci. Hum Mol Genet 2006;15:443-451.
• Landgren O, Linet MS, McMaster ML, Gridley G, Hemminki K, Goldin LR. Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: A population-based case-control study. Int J Cancer 2006;118:3095-3098.
• Fosså SD, Chen J, Schonfeld SJ, McGlynn KA, McMaster ML, Gail MH, Travis LB. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men. J Natl Cancer Inst 2005;97:1056-1066.
• Goldin LR, Landgren O, McMaster ML, Gridley G, Hemminki K, Li X, Mellemkjaer L, Olsen JH, Linet MS. Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiol Biomarkers Prev 2005;14:2402-2406.
• Nathanson KL, Kanetsky PA, Hawes R, McMaster M, et al. The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet 2005;77:1034-1043.
• Travis LB, Fosså SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice JD, Jr., Dores GM, Gilbert ES. Second cancers among 40,576 testicular cancer patients: Focus on long-term survivors. J Natl Cancer Inst 2005;97:1354-1365.